SHENZHEN, CHINA / ACCESSWIRE / November 18, 2020 / The reliable information shows that Pudu Robotics, a global commercial service robot company located in Shenzhen, China's R&D capital, will soon launch a new generation of disinfection robot "Puductor 2" to the global market after launching the first generation of disinfection robot "Puductor" successfully. The release of the new product will first target the European and American markets where the pandemic is relatively severe. With the aid of science and technology, Pudu hopes to provide support for medical institutions, governments, schools, airports, subway stations, banks and other public places around the world to fight against the pandemic.

"Puductor 2" is specially designed for the global battle on the pandemic, which is equipped with two disinfection modes of ultrasonic dry mist and UV-C, and comprehensively improves the disinfection ability of bacteria and viruses, especially for killing and cutting off the spread of the long-lasting COVID-19. On the one hand, "Puductor 2" ultrasonic dry mist disinfection mode adopts annular mist with a capacity of 15L disinfectant. Disinfectant is atomized into dry particles less than 10µm by ultrasonic atomization technology and sprayed into the air to suspend for a long time, thus ensuring full and complete contact between the disinfectant and microorganisms in the air for disinfection and sterilization. In the actual operation process, "Puductor 2" is provided with four gears to adjust the atomization rate and the amount of spray freely based on space requirements.

On the other hand, the newly mounted UV-C disinfection mode is equipped with a Philips UV lamp with an illuminance of 180μW/cm2 at 1 meter. Through the irradiation of ultraviolet lamp, bacteria and viruses can be killed without direct contact with objects, thus realizing 360°disinfection and become leading and effective in the whole industry. UV-C disinfection can not only be applicable to indoor air, but also for the surface of various objects, including desks and chairs, clothes, lockers, corridors in hospitals, temporary rescue centers, etc. In addition, the UV lamp of "Puductor 2" is fitted with a motorized interlocking mechanism, and it can be kept in a closed state under non-UV working conditions, which can avoid damage to the lamp caused by movement or impact.

Numerous studies have shown that ultraviolet mainly causes radiation damage and destruction of nucleic acid functions to kill microorganisms and realize the disinfection purpose, which can disinfect and kill 99.99% of dangerous viruses, bacteria, molds, spores and other harmful microorganisms, pathogens in daily life.

Supporting remote terminals to control the machine is another highlight of "Puductor 2". This function is a humanized design based on the personal safety of the operator. When operating, operators do not have to stand beside the robot. They can assign disinfection tasks to the robot through the remote terminal provided by Pudu Robotics, and receive notification at the end. At the same time, the liquid level of the disinfection solution tank can be detected in real time, and users will be reminded to supplement the solution in time when the liquid level is low. In order to facilitate the operators of public places and some private institutions to record and summarize the disinfection work, "Puductor 2" has added the function of automatically generating work reports and checking the disinfection in the area.

It is worth mentioning that "Puductor 2" adopts the Laser SLAM Auto-driving Solution, a laser positioning algorithm developed by Pudu Robotics. The multiple sensors embedded in the solution allow in-depth environment perception, which realize indoor automatic driving and synchronous positioning. At the same time, it supports remote driving, remote detection and high-precision positioning. Thanks to its strong adaptability, it can carry out disinfection work in clubs, libraries, exhibition halls, gymnasiums, concert halls, cinemas, game halls, trains and other places. In addition, "Puductor 2" is equipped with 2 batteries with a total capacity of 51.2Ah, which can disinfect 12-15 rooms (about 20㎡) at a time.

It is reported that "Puductor 2", the new generation of disinfection robot, will carry two disinfection modes of ultrasonic dry mist and UV-C, which improve the range and efficiency of disinfection. Users can switch between the two modes required by the scene. Moreover, compared with manual and fixed disinfection methods, robot disinfection can improve the safety, efficiency and effect of disinfection. In addition, "Puductor 2" has added a humanized remote-control function, which enables science and technology to serve human beings, improve production and living efficiency and make the product safe and reliable.

At present, "Puductor 2", the new generation of disinfection robot of Pudu, can be ordered worldwide. Let's fight against the pandemic together! Ordering email, global_sales@pudutech.com; Ordering tel.:+86 400-0826-660.

Learn more：https://pudurobotics.uk/

Contact:

Hilary Lee
+86 400-0826-660.
global_sales@pudutech.com

SOURCE: Pudu Robotics

ReleaseID: 617307

SOUTHFIELD, MI / ACCESSWIRE / November 18, 2020 / P&M Corporate Finance, LLC ("PMCF") is pleased to announce that it served as the exclusive financial advisor to Montway, Inc. ("Montway") and Ship.Cars (collectively, the "Company") in their sale to AEA Investors LP ("AEA").

PMCF Advises Montway and Ship.Cars in Sale to AEA Investors.

Headquartered in Schaumburg, IL (Montway) and Sofia, Bulgaria (Ship.Cars), Montway and Ship.Cars combine to offer leading automotive logistics solutions to consumers, auto haulers, and vehicle shippers across North America.

Montway is an asset-light, technology-enabled vehicle broker. It was founded to provide a user-friendly, hassle-free, and reliable platform for individual consumers to transport their vehicles. Since its founding in 2007, Montway has grown to become one of the largest business-to-consumer ("B2C") vehicle transport brokers in the United States.

Leveraging its expertise in data analytics and technology in the B2C market, Montway successfully expanded into the business-to-business ("B2B") sector, diversifying its customer base to serve automotive OEMs and their financial institutions, auction houses, rental car companies, and dealer groups for their vehicle transport needs. Today, Montway's service-oriented culture and technology-backed solutions provided by the Ship.Cars technology platform have propelled it to become one of the fastest growing vehicle transport brokers in the United States.

AEA is a leading private equity firm with committed funds targeting middle market investments. For this transaction, AEA partnered with industry veteran Tom Gartland, former President, North America for Avis Budget Group. Mihail Mihaylov, founder of Montway and Ship.Cars, remarked, "We are pleased to have found a partner in AEA with knowledge and resources that we can use to accelerate our growth trajectory. We are looking forward to working with AEA and Tom Gartland as we continue to grow and expand the business, while staying at the forefront of technology."

PMCF served as exclusive investment banker to the shareholders of Montway and Ship.Cars, managing the entire transaction process. Mihaylov added, "We hired PMCF to not only lead this transaction but advise us on deal preparation and timing to launch in order to maximize value. Completing a transaction during a global pandemic proved to be a complicated and challenging exercise, but the leadership and creativity of PMCF allowed us to complete a great transaction for our team."

The transaction closed in November 2020. Freeborn & Peters served as the legal advisor to the Company.

ABOUT PMCF

PMCF is a middle market investment bank providing merger and acquisition advisory services to private, public, and private equity owned companies. PMCF provides a broad range of services including sale advisory, acquisition advisory, capital raising, transaction planning and strategic advisory. The firm has dedicated professionals focused on plastics & packaging, business & technology services, automotive, distribution, transportation & logistics, aerospace & defense, medical technology, and consumer & retail industries. PMCF has offices in Chicago, Detroit, Denver, and globally through its ownership in Corporate Finance International™. For more information, visit www.pmcf.com.

Media contacts

Joe Wagner, Managing Director
P&M Corporate Finance (PMCF)
joe.wagner@pmcf.com

Mike Congleton, Vice President
P&M Corporate Finance (PMCF)
mike.congleton@pmcf.com

SOURCE: P&M Corporate Finance, LLC

ReleaseID: 617226

Renowned researchers, professional organizations, allied health organizations, advocacy organizations and patients are participating in AKF's Summit to chart a path forward

ROCKVILLE, MD / ACCESSWIRE / November 18, 2020 / The American Kidney Fund (AKF) today announced a first-of-its-kind initiative, the Unknown Causes of Kidney Disease Summit, to improve understanding of how undiagnosed or misdiagnosed causes of kidney disease directly impact patient care and outcomes. The Summit will take place virtually on Tuesday, Dec. 1, 2020.

AKF's Unknown Causes of Kidney Disease Summit will bring together medical leaders, patient advocates, and academic and industry researchers to identify how the kidney community can drive innovation in research, diagnosis and treatment of the underlying causes of kidney disease. Summit participants will review the research on this subject, hear directly from affected patients, identify barriers to progress, and develop a plan for a path forward to address this serious issue in nephrology. The Summit is made possible with generous funding from our Leadership Sponsors Natera, Otsuka America Pharmaceutical, Inc., Sanofi Genzyme, and Vertex Pharmaceuticals Incorporated, our Champion Sponsor Alexion Pharmaceuticals, and our Supporting Sponsor Travere Therapeutics, Inc.

While diabetes and hypertension are the two main causes of kidney failure, many other conditions can affect the kidneys and have serious health implications for patients. In many cases, kidney failure may be caused by a rare, genetic disease, putting family members at risk as well. If the cause of kidney failure is not accurately diagnosed, patients can experience serious consequences: delayed treatment, additional comorbidities, and even the loss of a transplanted kidney.

"Too many people crash into late-stage kidney disease or complete kidney failure without ever knowing the cause. In some cases, these patients may receive a kidney transplant but later lose the transplant because of an underlying condition that is attacking the kidneys-this is nothing short of tragic," said LaVarne A. Burton, AKF president and CEO. "In other cases of misdiagnosis, multiple family members experience kidney failure before realizing there is a genetic cause. We're grateful to the researchers, organizations and patients committing to work with us on this life-saving, unprecedented initiative."

AKF has appointed a national steering committee to lead this initiative. The steering committee will spearhead the publication of a white paper from the Summit participants' insights, with the goal of producing an actionable path forward. The committee will also form post-Summit working groups to advance solutions uncovered during the Summit. Committee members are:

David Baron, Ph.D.: Diagnosed with autosomal dominant polycystic kidney disease (ADPKD) in his 40s, Dr. Baron is a research scientist who has worked in academia at the Medical University of South Carolina, had a career in the pharmaceutical industry, and served as chief science officer for the PKD Foundation.
Ali Gharavi, M.D.: A leading kidney disease researcher, Dr. Gharavi is chief of the division of nephrology at New York-Presbyterian/Columbia University Medical Center, working to bring personalized genomic nephrology from the laboratory into patient care.
Kevin Ho, M.D.: Serving as medical director for U.S. medical affairs for rare diseases and rare kidney diseases at Sanofi Genzyme, Dr. Ho works to improve care outcomes for chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients.
Jack Johnson: As a Fabry disease patient and executive director and co-founder of the Fabry Support and Information Group, Johnson has spent more than two decades expanding understanding of this rare condition and improving the lives of patients living with Fabry disease.
Anna Köttgen, M.D.: A medical doctor and epidemiologist, Dr. Köttgen is head of the Institute of Genetic Epidemiology at the University of Freiburg (Germany) and is known worldwide for her expertise in the field of kidney disease genetics and complex renal and metabolic diseases.
Trudy McKanna, M.S.: A board-certified genetic counselor with over 20 years of experience in prenatal, pediatric, and laboratory genetic counseling, McKanna is director of medical education for transplant and renal genetics at Natera, where she works to enhance provider and patient education.
Silas Norman, M.D: A member of AKF's National Board of Trustees, Dr. Norman is a transplant nephrologist at University of Michigan Division of Nephrology. Dr. Norman is deeply involved in providing greater access to kidney transplants, particularly in medically underserved communities.
Julie Wright Nunes, M.D., MPH: AKF's Chair of Medical Affairs and a member of AKF's National Board of Trustees, Dr. Nunes is a physician scientist at the University of Michigan Division of Nephrology. In her role, Dr. Nunes works with patient-focused research at the forefront of patient and provider communication, patient health literacy, provider literacy and creating interventions that support patients learning about kidney disease, and what to do following a diagnosis of the disease.

"Kidney disease of unknown etiology is a very common condition, presenting a frustrating challenge for patients and clinicians," said steering committee member Dr. Gharavi. "This initiative is an exceptional endeavor, bringing together leading experts and advocates to chart a path forward that addresses critical science and clinical questions."

Organizations currently confirmed as Summit participants include: Alport Syndrome Foundation, American Association of Kidney Patients, American Nephrology Nurses Association, American Society of Nephrology, Chi Eta Phi Sorority, Inc., Dialysis Patient Citizens, IgAN Foundation, International Society of Nephrology, National Institute of Diabetes and Digestive and Kidney Diseases, National Kidney Foundation, National Medical Association, National Organization for Rare Disorders, National Society of Genetic Counselors, NephCure Kidney International, NEPTUNE Consortium, Oxalosis and Hyperoxaluria Foundation, Renal Pathology Society, Renal Physicians Association and the Veterans Health Administration.

To learn more about AKF's upcoming summit, please visit KidneyFund.org/summit.

About Us
The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation's leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease-from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. AKF is one of the nation's top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator and the Platinum Seal of Transparency from GuideStar.

For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter and Instagram.

Contacts
Melissa Zuckerman
11921 Rockville Pike, Suite 300, Rockville, MD 20852
Work: 202-591-4021 Mobile: 561-714-7091
AKF@jpa.com
KidneyFund.org

Links
https://www.kidneyfund.org/summit

SOURCE: American Kidney Fund

ReleaseID: 617227

Shop WidePointMobile.com for Mobile Devices and Accessories Now through the Holidays and Save 30% on Orders of More than $20 with Discount Code "Launch30"

FAIRFAX, VA / ACCESSWIRE /  November 18, 2020 / WidePoint Corporation (NYSE American:WYY), the leading provider of Trusted Mobility Management (TM2) specializing in Telecommunications Lifecycle Management, Identity Management and Digital Billing & Analytics solutions, today announced the launch of the WidePoint TM2 Store at widepointmobile.com.

"WidePoint is one of the leading resellers of mobile devices and accessories to government organizations," said Jin Kang, WidePoint's CEO. "The expertise that we've developed from our long history of successful work in the government space, including our work with the U.S. Department of Homeland Security, the U.S. Army Corps of Engineers, the Centers for Disease Control and Prevention and the 2020 U.S. Census, gives us a unique understanding of how to best support complex procurement initiatives. After we've expanded sales to more commercial clients, we've realized that other government and commercial enterprises could benefit from the volume discount deals that we are able to offer."

The WidePoint Sales Team works with enterprise clients to secure sought-after items, such as Apple iPhones, iPads and Chromebooks, and to fulfill specific procurement needs. Clients now have another avenue to procure equipment, accessories and peripherals through the Widepoint TM2 Store which offers discounts of up to 25% off MSRP. Bestsellers include OtterBox, Naztech, Samsung and iPhone compatible accessories, among others.

Todd Dzyak, President of WidePoint Mobile Corporation, stated, "The WidePoint TM2 Store was launched to enable our clients and their staffs to benefit from significant price discounts on their corporate and personal mobile equipment needs. Beyond selling more mobile devices, accessories and peripherals, the store also expands WidePoint's distributor and reseller relationships and opportunities."

Kang added, "WidePoint is commiteed to developing and expanding our Trusted Mobility Magenement (TM2) framework. By supporting organizations in their procurement initiatives, WidePoint looks forward to serving more TM2 enterprise clients. The WidePoint TM2 Store will support our goal of increasing our equipment and accessory sales by 10% to 30% to increase our profits up to 25%."

For organizations and individuals shopping for mobile devices and accessories now through the holidays, WidePoint is offering 30% off on any and all orders of more than $20 placed before December 31, 2020. Use the discount code "Launch30" at checkout.

About WidePoint

WidePoint Corporation (NYSE American:WYY) is a leading provider of trusted mobility management (TM2) solutions, including telecom management, managed mobility services, identity management, and digital billing and analytics. For more information, visit widepoint.com.

Investor Relations:

Gateway Investor Relations
Matt Glover or Charlie Schumacher
949-574-3860, WYY@gatewayir.com

SOURCE: WidePoint Corporation

ReleaseID: 617250

Provides advancement for its immunotherapy technology against brain tumors into human clinical trials

CLEVELAND, OH / ACCESSWIRE / November 18, 2020 / NovAccess Global Inc. (OTC PINK:XSNX) (the "Company" or "NovAccess"), a cancer therapeutics company with operations in biotechnology is thrilled to announce that it has an unlimited use license to an approved US Patent # 9764014, which was obtained in September 2020 when NovAccess acquired StemVax Therapeutics. The structure of the technology transfer agreement in place is commensurate with other significant technology transfers in the pharmaceutical industry, and affords NovAccess the commercial benefits of the technology going forward.

Glioblastoma multiforme (GBM) is the most common adult brain tumor with less than a 15-month median survival and no cure. Despite advances in chemotherapy and radiation therapy over the last 30-40 years, there has been no significant improvement in survival time for GBM patients. Currently, there is no immunotherapy for treating brain tumor patients available in the market. NovAccess Global is very excited about the potential of this novel approach to treating brain cancer through the license.

The technology was initially developed at the Department of Neurosurgery, at a major California research hospital by Dr. Dwain Irvin, NovAccess Chief Executive Officer, a Research Scientist and Assistant Professor (2005-2013) at the hospital at that time. Dr. Chris Wheeler, President of StemVax Therapeutics Inc., will lead the filing of an Investigational New Drug (IND) application with the FDA to obtain approval for starting human clinical trials. Dr. Wheeler's over 20 years' experience and involvement in developing immunotherapy protocols to treat brain cancer, including multiple filed patents and significant contribution to StemVax IP, brings established experience, added expertise, and team cohesiveness to StemVax Therapeutics.

About NovAccess Global
NovAccess Global is a biomedical company accelerating novel cancer diagnostics and therapeutics. Our goal is discover, develop and bring to market novel and innovative medicine and medical devices to improve the quality of care for cancer and neurological patients. NovAccess Global is a currently developing a cancer vaccine therapy that enhances the patient's immune response against brain tumors. Our company has a novel immunotherapeutic approach to treat brain tumor patients with glioblastoma multiforme, the most common adult brain tumor with a 15-month median survival after diagnosis. Our patented technology is designed to combine a dendritic cell-based immunotherapeutic approach with a unique combination of Toll-like receptor (TLR) adjuvants, TLR-AD1, to help promote an enhanced immune response against the patient's tumor. Our platform technology focuses on enhancing the patient's immune cells to fight their unique cancer by utilizing the antigens specific to the patient's tumor. The company owns a cancer vaccine, which is a medication that stimulates or restores the immune system's ability to fight an existing cancer by strengthening the body's natural defenses against the cancer cells. It is a meaningful technology which could significantly improve the quality of life and prognosis for the many people who suffer from brain tumors. For more information, please visit novaccessglobal.com.

Forward-Looking Statement
This email and its attachments contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude or risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in the Company's disclosures or filings with the Securities Exchange Commission and/or OTC Markets, Inc. You are further cautioned that penny stocks and stocks of smaller companies like Innovest Global, Inc. are inherently volatile and risky and that no investor should buy this stock unless they can afford the loss of their entire investment. The Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date thereof.

Investor Relations Contact:
Satya Chillara
Darrow Associates
(510) 396 -2776
schillara@darrowassociates.com

Broker, and Analyst Contact:
Chesapeake Group
+1 (410) 825-3930
info@chesapeakegp.com

SOURCE: NovAccess Global Inc.

ReleaseID: 617179

Manolo Valdés has exhibited around the world, yet chose Miami to showcase his largest outdoor exhibition to date, "The Legacy," which opens to the public during Miami Art Week, Dec. 1-6 and continues until June 2021

MIAMI, FL / ACCESSWIRE / November 18, 2020 / An outstanding selection of more than a dozen larger-than-life sculptures will be featured in Miami, the first exhibition of this magnitude with 12 locations and approximately 18 pieces. ‘Manolo Valdés: The Legacy' will open in time for the celebration of Miami Art Week, with a public event at Doral Central Park on Saturday, December 5, 2020, at 11:00 a.m., all produced by the Doral Contemporary Art Museum (DORCAM) and sponsored by the City of Doral and Miami-Dade County.

His solo exhibitions include prestigious galleries and museums throughout the world, including the Guggenheim in New York, the Hirschhorn in Washington, DC, and multiple art capitals such as London, Berlin, Paris, Milan, Rome, Seoul, Istanbul, The Hague, and Monaco, among others.

In partnership with the City of Doral, the monumental sculptures will be installed in the main public parks of the City of Doral, including Doral Central Park, Downtown Doral Park, MAU Park, Morgan Levy Park, Doral Legacy Park, and Doral Glades Park, as well as other selected locations. The Doral Contemporary Art Museum (DORCAM) exhibition will be the largest exhibition of his epic sculptures to date.

"With Art Basel not occurring this year due to the COVID-19 pandemic, residents and visitors can safely experience art, considering that public art is probably the safest way to enjoy art in the current global health conditions," said Dr. Flor Mayoral, co-founder of DORCAM. "The Legacy by Manolo Valdés will be the largest exhibition ever for this world-renowned contemporary art master."

The exhibition will be on view for six months, until June 2021, with several programs organized around the exhibition throughout its duration, such as guided tours, educational programs for students, public workshops and lectures, photography competitions, pop-up exhibitions, performances, and the publication of a special-edition book, among others.

"We are sure this grandiose exhibition will bring a lot of joy in a year when good news has been scarce, and it is sure to attract numerous visitors," said Marcelo Llobell, co-founder of DORCAM.

The sizeable scale of this urban exhibition by one of the most influential artists of our times will transform the city into an experiential space and will put Miami-Dade County in the company of other great capitals, where the artist has also shown his monumental sculptures in public places. Additional support for this exhibition has been provided by the Miami-Dade County Department of Cultural Affairs and The Greater Miami Convention and Visitors Bureau. For more information on the exhibition, please visit www.Dorcam.org.

About Manolo Valdés
Manolo Valdés, born in Valencia, Spain in 1942, showed proficiency in art from an exceedingly early age and currently is one of the most internationally celebrated contemporary artists. He is multidimensional, and masterful in mediums such as painting, mixed media, and sculpture. He has received several awards and recognitions throughout his illustrious career, such as representing his homeland in the 1999 Venice Biennale. His solo exhibitions include prestigious galleries and museums throughout the world, including the Guggenheim in New York, the Hirschhorn in Washington, DC, and multiple art capitals such as London, Berlin, Paris, Milan, Rome, Seoul, Istanbul, The Hague, and Monaco, among others.

About Doral Contemporary Art Museum
Doral Contemporary Art Museum (DORCAM) is a catalyst for learning, creativity, and community building. Our mission is to create a concept that integrates artists and audiences through the presentation of contemporary art in ways that highlight what it means to be a citizen of both Doral and the world. Through the integration of art + industry, we produce contemporary art exhibitions, educational programs, community partnerships, and creative economy initiatives.

Media Contacts:
The Conroy Martinez Group, 305-445-7550
Janice Betti, Janice@conroymartinez.com

SOURCE: Doral Contemporary Art Museum

ReleaseID: 617235

Market players are investing in R&D to satiate the requirement for eco-friendly and cost-effective alternatives.

DUBAI, UAE / ACCESSWIRE / November 18, 2020 / Future Market Insights: The metal container market will reflect a CAGR of 6 % over the forecast period 2020-2030. The market is primarily driven by growing health awareness among consumers. Extensive use in packaging of several products such chemicals, as paints and dyes, automotive, healthcare and pharmaceutical, personal care and cosmetics products, and others further generate growth prospects.

"The metal container market will foresee a surge in demand due to the growing use of RFID technology, increasing implementation of recyclable metal containers, and growing chemical sector." concludes the FMI analyst.

Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-9432

Key Highlights

Europe accounts for largest market share due to high sales and production of intermediate bulks containers.

Intermediate bulks containers is projected to grow at a CAGR of 6.9% over the forecast period.

Steel remains the key beneficiary due to its varied advantages over other materials.

Food and beverage sector will remain lucrative throughout the forecast period.

Drivers

Cost-effectiveness of containerization will reflect significant growth of the market in the approaching years.

Multi-directional growth of the chemical sector is steadily propelling the demand for metal containers.

RFID technology is anticipated to come out as an efficient cost-saving tool for consumers and profitable for manufacturers.

Rising cautiousness among consumers regarding sanitation has led to metal packaging since they are airtight and avert tampering risk.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-9432

Restraints

Growing environmental and health concerns are generating prospects for bio-based plastics such as polyethylene terephthalate, bagasse which will might hinder the growth of metal containers.

Rising trends favoring the usage of light-weight substitutes has prompted a drop in demand for metal packaging.

COVID-19 Impact on the Market

Production activities of the worldwide market have been affected due to COVID-19 led restrictions imposed by governments and present deceleration of end use sector. However with the growing need for well packaged products in the pharmaceutical and food sectors has boosted demand for metal containers. Furthermore, with change in people's lifestyle towards more safe and health cautious one, the need for low error packages is high and would benefit the market.

Competitive Landscape

Major companies identified in the metal containers market are Ardagh Group S.A., Ball Corporation, CCL Industries Inc., Silgan Holdings Inc., CPMC Holdings Ltd., Grief Inc., Crown Holdings, Inc., Toyo Seikan Co., Ltd., Mauser Packaging Solution, Montebello Packaging Inc., Nampak Ltd., Balmer Lawrie & Co. Ltd., NCI Packaging, HUBER Packaging Group GmbH, and Great Western Containers Inc.

Buy Now@ https://www.futuremarketinsights.com/checkout/9432

About the Study

The study offers readers a comprehensive assessment of the metal containers market. Global, regional and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights according to product type(cans, drums, aerosol cans, pails, intermediate bulk containers, others), material type (steel, aluminium, tin), end use (food and beverage industry, chemicals, automotive, pharmaceutical & healthcare, cosmetics & personal care, building & construction, other end use), across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).

Explore FMI's Coverage of the Packaging Industry

Bi-metal Cans Market: Get insights on the bi-metal cans market through FMI's report covering detailed quantitative and qualitative analysis for projection period 2019-2029.

Pressurized Metal Containers Market: FMI's exhaustive study on the global pressurized metal containers market covers the latest trends, innovations, key players, and popular strategies for the period 2020 – 2030.

Two Piece Metal Containers Market: Obtain detailed analysis on the two piece metal containers market through FMI's report covering competitive analysis, key regions, and segmental analysis for 2020 – 2030.

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/metal-containers-market

Press Release Source: https://www.futuremarketinsights.com/press-release/metal-containers-market

SOURCE: Future Market Insights

ReleaseID: 617282

PHOENIX, AZ / ACCESSWIRE / November 18, 2020 / Alpine 4 Technologies, Ltd., (OTCQB:ALPP) a leading operator and owner of small market businesses, welcomes Spencer Gore to the team as a corporate strategy consultant. On November 13th, 2020, the company entered into a two-year agreement with Mr. Gore with three primary goals. The first was to help in the transfer of IP associated with the sale of Impossible Aerospace to Alpine 4. The second was to help Alpine 4 capitalize on Mr. Gore's extensive knowledge of commercial drones and his experience in battery technologies. Finally, the company feels that Mr. Gore's time spent with Tesla and Space X will help Impossible Aerospace execute on the growing demand from the US Air Force for domestically made electric aircraft.

Mr. Gore had this to say, "I am thrilled to join the Alpine 4 team for the next chapter of Impossible Aerospace. Our company has spent the past four years developing unique, defensible technology to enable drones with unrivaled performance. Now, with Alpine 4's manufacturing prowess and revenue engine, it's time to scale. I am honored to be given the opportunity to help oversee Impossible's future product, technology, and business strategy, and will be there every step of the way to ensure a smooth merger of our companies."

Kent Wilson, CEO of Alpine 4, had this to say. "Experience always plays well with initiative and the addition of Mr. Gore to the Alpine 4 team will pay great dividends as we roll out our plans to build Impossible Aerospace into the nations leading electric aircraft manufacturer.

Spencer Gore, based out of Silicon Valley, was the founder and chief executive officer of Impossible Aerospace Corporation since 2016. He previously served as a battery design engineer at Tesla Motors, where he developed the world's longest-range electric vehicle battery for the Model S. Prior to that, Gore also developed aerospace technology at both SpaceX and NASA Goddard Space Flight Center. He is an alumnus of the University of Illinois, Urbana-Champaign, where he studied physics.

\\Alpine 4: Four principles at the core of our business are Synergy. Innovation. Drive. Excellence. At Alpine 4, we believe synergistic innovation drives excellence. By anchoring these words to our combined experience and capabilities, we can aggressively pursue opportunities within and across vertical markets. We deliver solutions that not only drive industry standards but also increase value for our shareholders.

Contact: Kent B. Wilson, CEO or Ian Kantrowitz, VP of Investor Relations

investorrelations@alpine4.com

www.alpine4.com

Forward-Looking Statements: The information disclosed in this press release is made as of the date hereof and reflects Alpine 4 most current assessment of its historical financial performance. Actual financial results filed with the SEC may differ from those contained herein due to timing delays between the date of this release and confirmation of final audit results. These forward-looking statements are not guarantees of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements including, without limitation, the risks, uncertainties, including the uncertainties surrounding the current market volatility, and other factors the Company identifies from time to time in its filings with the SEC. Although Alpine 4 believes that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate and, as a result, the forward-looking statements based on those assumptions also could be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained in this release are made as of the date hereof, and Alpine 4 disclaims any intention or obligation to update the forward-looking statements for subsequent events.

SOURCE: Alpine 4 Technologies, Ltd.

ReleaseID: 617296

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, BC / ACCESSWIRE / November 18, 2020 / Tracesafe Inc., ("TraceSafe") (CSE:TSF) a global leader in wearable safety tech, including contact tracing and quarantine management, is pleased to announce it has won the Singapore National Innovation Challenge ("NIC") award for "Digital Tool to Facilitate a COVID-Safe, Smart and Integrated Management of Worksite and Workforce." The NIC initiative provides support for the development, deployment and adoption of solutions to address nationwide challenges, as well as medium to long-term solutions for businesses to emerge stronger in the post-COVID environment. This award specifically acknowledges TraceSafe as a leader in these solutions.

This award will fast track TraceSafe projects in Singapore and advance funding up to SGD$300,000 immediately. In addition, it allows other industry participants to get up to 50% of their cost paid by IMDA to encourage rapid adoption subject to certain program parameters.

The challenge was sponsored by Boustead and co-funded by Singapore's Infocomm Media Development Authority (IMDA). It is a multi-step process to include Project Planning & Design Scoping, Conversational Mapping, Modelling & Ingestion, Platform Development, and Prototype Launch. This award will provide a platform and funding for TraceSafe to further develop and deploy their quarantine management and contact tracing solutions throughout Singapore. TraceSafe's selection for this award will bolster their reputation throughout the region as a leading option for businesses and local governments looking for quarantine management solutions as they work toward a post-COVID world.

Through NIC, challenge winners gain access to a diverse pool of problem solvers across a range of industries. Winners receive support and funding to deploy their solutions into the market swiftly and effectively. TraceSafe was specifically chosen because they provide a robust monitoring system both on-site and offsite to manage the workforce-readiness status and enable movement control on-site to minimise the risk exposure. Previous winners of this award have gone on to successfully deploy their solutions across industries, organize multiple successful rounds of investment, and gone on to see their solutions adopted widely and effectively on a commercial scale.

Executive Quote

"We are honored to have been selected for Singapore's National Innovation Challenge. As a leading provider in the field of contact tracing and quarantine management solutions, this is further validation of our team's outstanding work in the region", said TraceSafe's CEO Wayne Lloyd. "This is a testament to the high caliber of work our team has done in deploying and managing the TraceSafe suite of products in Singapore and will translate into tangible benefits for both TraceSafe and our customers."

About TraceSafe

TraceSafe is a full suite of real-time location management services and contact tracing solutions enabled through advanced low power bluetooth beacons and enterprise cloud management. TraceSafe's leading cloud management solution ensures both user privacy and comprehensive administrative control. TraceSafe's patented contact tracing bracelet has already been deployed in mission critical quarantine applications around the world in partnership with leading governments. In addition to their government work, TraceSafe is developing leading edge solutions for Enterprise, Healthcare, Education Government and large-scale venue management.

For further information, please contact:

Wayne Lloyd, CEO
+1 604 629-9975
wayne@tracesafe.io

Alan Tam, CFO
+1 604 377‐7575
alantamca@gmail.com

John Costigan
+1 604 620-8589
jcostigan@ecmbcapital.com

The Canadian Securities Exchange has in no way approved or disapproved the contents of this news release.

Statements in this news release may contain forward-looking statements that are based on TraceSafe's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to expectations regarding the TraceSafe assets and their application, future business plans and relationships, future developments in respect of COVID-19 and solutions adopted in response to the virus, and the deployment and acceptance of the TraceSafe technology. Although TraceSafe believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict, including the suitability of our products to help businesses and governments reopen, competition, the spread or containment of COVID-19 and government responses thereto and general economic and market conditions. Therefore, outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and TraceSafe undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.

SOURCE: Tracesafe Inc.

ReleaseID: 617272

Market players are focusing on research & development and deployment of ML-based various agent archetype to remain ahead of the competition.

DUBAI, UAE / ACCESSWIRE / November 18, 2020 / Future Market Insights: The AI-enabled testing tools market is expected to grow at an impressive CAGR of 13% during the assessment period 2020-2030. The market is primarily driven by growing digital transformation and technological revolution in the telecom industry to offer comprehensive variety of services to users.

"AI has assisted telecom companies' scale up revenues and growth, together with enhancing network capacities and letting faster processing of huge amounts of data. With use of connected devices rise steeply, more CSPs are jumping on the bandwagon, discovering the potential of AI-enabled testing tools market." concludes the FMI analyst.

Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-12757

Key Highlights

North America will remain epicentre of value-capture prospects, due to sturdy presence of technology pioneers.
AI enabled solutions will witness a rise in investment over the forecast period.
ML and pattern recognition technology category will continue to account for a highest revenue share during the forecast period.
Quality and User Experience (UX) to gain traction throughout the forecast period.

Drivers

AI enabled testing tools offer efficient customer service and network operation, thus pushing market growth.
Self-healing testing are likely to boost the overall market growth throughout the forecast period.
Consistent rise in bandwidth expectations, traffic volume, network size, and service complexity, is swaying CSPs to fulfil innovative approaches for network operations and customer assurance, hence fueling the market growth.

Restraints

Technical challenges such as finding the right skills and experience, reliable test environment and building flexible test automation architecture can hinder the market growth.
ML (Machine learning) still necessitates lots of training data, which interprets into several actual human work, thus limiting the growth of the market.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-12757

COVID-19 Impact on the Market

COVID-19 pandemic has fast-tracked the implementation of AI-enabled testing tools to help companies leverage them to their benefit. With WFH (work from home) being accepted as the new normal amid the crisis, deployment of enterprise-level ICT (information and communication technology) is rising. Furthermore, telecom operators are banking on automation enhancement tools and remotely operable solutions to ascertain finest functioning and counter lag in efficiency. This, in turn, is encouraging market growth.

Competitive Landscape

Major companies operating in the AI-enabled Testing Tools market are testim, Sauce Labs Inc., ReTest GmbH, Appdiff, Inc., SOFY, ReportPortal.io, Eggplant, Diffblue Ltd., Functionize Inc., apptest.ai Inc., AutonomIQ, mabl Inc., SeaLights, Applitools and testRigor. The companies are increasingly investing in research & development activities to remain ahead of curve.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/12757

About the Study

The study offers readers a comprehensive assessment of the AI-enabled Testing Tools market. Global, regional and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights according to Solution (AI-based Tools(Data Wrangling and Pre-processing, Data Visualization, Feature Selection and Reduction and Others)and Services(Professional Services and Managed Services)), Technology(Machine Learning and Pattern Recognition, Natural Language Processing (NLP) and Computer Vision and Image Processing), and Application(Agility and Coverage(Test and Maintenance Case Generation and Test and Maintenance Optimization), Quality and User Experience (UX)(Coverage and Risk Analytics and Defect Prediction and Prevention),Efficiency and Time-to-Market(Test Automation, Infrastructure Optimization and Data Analytics)), across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).

Explore FMI's Coverage of the Technology Industry

AI Platform Market: Get insights on the AI platform market through FMI's report covering detailed quantitative and qualitative analysis for projection period 2018-2028.

AI Consulting Services Market: FMI's exhaustive study on the global AI consulting services market covers the latest trends, innovations, key players, and popular strategies for the period 2020 – 2030.

AI-enabled Diagnostic Imaging Market: Obtain detailed analysis on the AI-enabled diagnostic imaging market through FMI's report covering competitive analysis, key regions, and segmental analysis for 2020 – 2030.

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/ai-enabled-testing-tools-market

Press Release Source: https://www.futuremarketinsights.com/press-release/ai-enabled-testing-tools-market

SOURCE: Future Market Insights

ReleaseID: 617287